D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 57 Citations 9,328 252 World Ranking 1996 National Ranking 92

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Disease

Peter Richmond mainly focuses on Immunology, Vaccination, Immunogenicity, Virology and Microbiology. His works in Antibody, Innate immune system, Immune system, Serotype and Avidity are all subjects of inquiry into Immunology. His research in Vaccination intersects with topics in Titer, Adverse effect, Immunization, Seroconversion and Pediatrics.

His Immunogenicity research is multidisciplinary, incorporating elements of Neisseria meningitidis, Meningococcal vaccine, Orthomyxoviridae and Adjuvant. His Virology study combines topics from a wide range of disciplines, such as Reactogenicity, Conjugate vaccine and Meningococcal disease. His research on Microbiology also deals with topics like

  • Biofilm most often made with reference to Middle ear,
  • Otitis which intersects with area such as Bacteria and Antibiotics.

His most cited work include:

  • Effects of probiotics on atopic dermatitis: a randomised controlled trial (338 citations)
  • Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory (217 citations)
  • Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers (202 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Vaccination, Pediatrics, Virology and Internal medicine. His Immunology research is multidisciplinary, relying on both Haemophilus influenzae and Streptococcus pneumoniae. Peter Richmond interconnects Adverse effect and Immunization, Reactogenicity in the investigation of issues within Vaccination.

The concepts of his Pediatrics study are interwoven with issues in Epidemiology, Cohort study, Incidence, Disease and Prospective cohort study. His work deals with themes such as Gastroenterology and Placebo, which intersect with Internal medicine. His Immunogenicity research integrates issues from Neisseria meningitidis and Meningococcal vaccine.

He most often published in these fields:

  • Immunology (71.69%)
  • Vaccination (50.65%)
  • Pediatrics (37.14%)

What were the highlights of his more recent work (between 2019-2021)?

  • Vaccination (50.65%)
  • Internal medicine (23.12%)
  • Immunology (71.69%)

In recent papers he was focusing on the following fields of study:

Peter Richmond focuses on Vaccination, Internal medicine, Immunology, Pediatrics and Diphtheria. His Vaccination study incorporates themes from Adverse effect, Seroconversion, Incidence and Reactogenicity. As part of the same scientific family, Peter Richmond usually focuses on Internal medicine, concentrating on Immunogenicity and intersecting with Transplantation, Influenza vaccine, Institutional review board, Oncology and Clinical trial.

Pertussis vaccine, Antibody, Immune system, Immune Dysfunction and Vaccine response are among the areas of Immunology where the researcher is concentrating his efforts. Peter Richmond has researched Pediatrics in several fields, including Readmission risk, Hospital readmission, Risk factor and Hazard ratio. His studies in Diphtheria integrate themes in fields like Antigen, Immunoassay, Vaccine-preventable diseases, Poliomyelitis and Conjugate vaccine.

Between 2019 and 2021, his most popular works were:

  • Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. (47 citations)
  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. (44 citations)
  • Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial. (25 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Disease

His scientific interests lie mostly in Vaccination, Internal medicine, Odds ratio, Seroconversion and Influenza vaccine. He combines subjects such as Relative risk, Pediatrics and Reactogenicity with his study of Vaccination. His Internal medicine study integrates concerns from other disciplines, such as Meningococcal carriage and MENINGOCOCCAL B.

Peter Richmond has included themes like Neisseria meningitidis, Meningococcal disease, Randomized controlled trial, Group B and Invasive group in his Odds ratio study. His Seroconversion research incorporates themes from Adjuvant, Placebo, Adverse effect and Immunogenicity. His study on Adjuvant is covered under Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effects of probiotics on atopic dermatitis: a randomised controlled trial

Stephanie Weston;Anne R Halbert;Peter Richmond;Susan L Prescott.
Archives of Disease in Childhood (2005)

514 Citations

Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory

Peter Richmond;Ray Borrow;Elizabeth Miller;Sarah Clark.
The Journal of Infectious Diseases (1999)

298 Citations

Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers

Peter Richmond;Ray Borrow;David Goldblatt;Jamie Findlow.
The Journal of Infectious Diseases (2001)

285 Citations

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Terry Nolan;Jodie McVernon;Maryanne Skeljo;Peter Richmond.
JAMA (2010)

240 Citations

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

Keith Cartwright;Rhonwen Morris;Hans Rümke;Andrew Fox.
Vaccine (1999)

233 Citations

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1

S. W. Knight;N. S. Heiss;T. J. Vulliamy;C. M. Aalfs.
British Journal of Haematology (1999)

229 Citations

Innate immunity in human newborn infants: prematurity means more than immaturity.

Tobias Strunk;Andrew Currie;Peter Richmond;Karen Simmer.
Journal of Maternal-fetal & Neonatal Medicine (2011)

219 Citations

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.

David Goldblatt;Jo Southern;Lindsey Ashton;Peter Richmond.
Pediatric Infectious Disease Journal (2006)

207 Citations

Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults That Is Overcome by Meningococcal C Conjugate Vaccine

Peter Richmond;Ed Kaczmarski;Ray Borrow;Jamie Findlow.
The Journal of Infectious Diseases (2000)

192 Citations

Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis

Susan Prescott;Janet Dunstan;J. Hale;L.A. Breckler.
Clinical & Experimental Allergy (2005)

189 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter Richmond

Ray Borrow

Ray Borrow

Manchester Royal Infirmary

Publications: 99

Ofer Levy

Ofer Levy

Boston Children's Hospital

Publications: 96

Andrew J. Pollard

Andrew J. Pollard

University of Oxford

Publications: 89

Anne B. Chang

Anne B. Chang

Boston Children's Hospital

Publications: 59

David Goldblatt

David Goldblatt

University College London

Publications: 47

Kathrin U. Jansen

Kathrin U. Jansen

Pfizer (United States)

Publications: 44

Keith Grimwood

Keith Grimwood

Griffith University

Publications: 42

Peter McIntyre

Peter McIntyre

University of Otago

Publications: 40

Jonathan R. Carapetis

Jonathan R. Carapetis

University of Western Australia

Publications: 40

Elizabeth Miller

Elizabeth Miller

University of Pittsburgh

Publications: 36

Stephen B. Lambert

Stephen B. Lambert

Australian National University

Publications: 36

Adam Finn

Adam Finn

University of Bristol

Publications: 35

Tobias R. Kollmann

Tobias R. Kollmann

Telethon Kids Institute

Publications: 32

Paul T. Heath

Paul T. Heath

St George's, University of London

Publications: 31

Mimi L.K. Tang

Mimi L.K. Tang

Royal Children's Hospital

Publications: 30

Robert Booy

Robert Booy

University of Sydney

Publications: 29

Something went wrong. Please try again later.